Pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis. Case report and literature review.
Interferon-β
Multiple sclerosis
Pulmonary arterial hypertension
Journal
Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
24
11
2018
revised:
03
01
2019
accepted:
04
01
2019
pubmed:
15
1
2019
medline:
14
6
2019
entrez:
15
1
2019
Statut:
ppublish
Résumé
Drug-Induced Pulmonary Arterial Hypertension (PAH) represents a well-known entity, predominantly related to anorexigens. Interferon-β (IFN) is considered to be a drug with a possible risk of inducing PAH. We report a patient with Multiple Sclerosis treated with IFN-β who diagnosed with PAH and her course of disease under specific PAH drug therapy. A review of the literature in IFN-β-induced PAH is provided.
Identifiants
pubmed: 30639829
pii: S2211-0348(19)30018-5
doi: 10.1016/j.msard.2019.01.018
pii:
doi:
Substances chimiques
Immunologic Factors
0
Interferon-beta
77238-31-4
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
273-275Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.